Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Alkem Laboratories Ltd

NSE: ALKEM · BSE: 539523 · Pharmaceuticals & Biotechnology · 49 announcements

Alkem Laboratories Ltd news stories on ALFA NewsRead the news →
Share price
₹5,350.50
Market cap
₹63,973 Cr
Revenue (annual)
₹14,712 Cr
Net profit (annual)
₹2,302 Cr
P/E (TTM)
29.6×Sector 47.3×
Promoter holding
49.70%-1.50% QoQ
FII holding
10.42%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:10 IST NSE
Other Announcement

Alkem Laboratories Other Announcement

Alkem Laboratories notified the exchange that it dispatched web-links for the FY 2025-26 Annual Report to unregistered shareholders. This filing fulfills Regulation 36(1)(b) compliance requirements.

11:23 IST BSE
Other Announcement

Alkem Laboratories Other Announcement

Alkem Laboratories submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms overall regulatory adherence with no major non-compliance observations.

Execution
Financial Year ended March 31, 2026
14:30 IST NSE
Other Announcement

Alkem Laboratories Other Announcement

Alkem Laboratories' promoter, Basudeo N. Singh, has declared that the promoter group made no direct or indirect encumbrances on their shareholding during FY 2025-26. This is a routine annual compliance disclosure under SEBI Takeover Regulations.